Media ReleasesImmutep

View All Immutep News


Immutep to present at upcoming industry conferences

SYDNEY, AUSTRALIA – May 10, 2019 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announces participation at upcoming industry conferences. 

For further information please download PDF attached:
Download this document